DVN
47
3
BIIB
38
2
DFS
62
-5
CAT
61
-9
PX
12
-4
PDCO
57
-3
XRAY
34
-3
HBI
17
-11
EFX
58
14
PSA
33
-8
GWW
58
-2
STI
75
29
VRTX
58
-2
PFG
45
-4
AMAT
57
3
AMG
36
-7
GOOG
79
-4
MCHP
62
3
EL
46
-6
SLG
59
-3
DVN
47
3
BIIB
38
2
DFS
62
-5
CAT
61
-9
PX
12
-4
PDCO
57
-3
XRAY
34
-3
HBI
17
-11
EFX
58
14
PSA
33
-8
GWW
58
-2
STI
75
29
VRTX
58
-2
PFG
45
-4
AMAT
57
3
AMG
36
-7
GOOG
79
-4
MCHP
62
3
EL
46
-6
SLG
59
-3
Financhill
Back

Theriva Biologics 10K Form

Sell
39

TOVX
Theriva Biologics

Last Price:
0.42
Seasonality Move:
386.92%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TOVX News And Ratings

See the #1 stock for the next 7 days that we like better than TOVX

TOVX Financial Statistics

Sales & Book Value

Annual Sales: $2.61M
Cash Flow: $-6.6M
Price / Cash Flow: 0
Annual Sales: $2.16
Price / Book: 0.19

Profitability

EPS (TTM): -1.16000
Net Income (TTM): $-18.35M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

Theriva Biologics Earnings Forecast

Key Theriva Biologics Financial Ratios

  • The Selling, General & Administrative Expenses for TOVX have been equal to 80.99% of Gross Profit Margin.
  • The Interest Expense is -0.26% of Operating Income.
  • Per Share Earnings over the last 19 years have been positive in 14 years.

Theriva Biologics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYAM
Industry: Biotechnology
Sector: Health Care
Current Symbol: TOVX
Website: therivabio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

TOVX Technical Analysis vs Fundamental Analysis

Sell
39
Theriva Biologics (TOVX) is a Sell

Is Theriva Biologics a Buy or a Sell?

  • Theriva Biologics stock is rated a Sell
    The current Theriva Biologics [TOVX] share price is $0.41. The Score for TOVX is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.